Rare diseases
Investigational molecules
Locations
Back to Hungary346 clinical trials in Pecs, Hungary across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on Long-Term Safety and Efficacy of BI 1291583 in Patients with Bronchiectasis
HungaryStudy Comparing MK-1308A and Pembrolizumab for Patients with Advanced Colorectal Cancer with High Microsatellite Instability or Mismatch Repair Deficiency
HungaryStudy on BI 764524 for Patients with Moderate to Severe Diabetic Retinopathy
HungaryStudy of Rocatinlimab in Adults with Prurigo Nodularis Not Adequately Controlled by Topical Treatments
HungaryStudy on Talazoparib and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer
HungaryStudy on the Effectiveness and Safety of Frexalimab and Teriflunomide in Adults with Relapsing Multiple Sclerosis
HungaryStudy on Aticaprant for Adults with Major Depressive Disorder and Anhedonia Not Responding to Antidepressants
HungaryStudy on the Effects of CDR132L in Patients with Reduced Heart Function After a Heart Attack
HungaryStudy on the Effects of Povetacicept for Adults with IgA Nephropathy
HungaryStudy on EYE103 and Ranibizumab for Patients with Diabetic Macular Edema
HungaryThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on innovative treatments for chronic rhinosinusitis and asthma, with studies evaluating new therapeutic approaches for both conditions with and without nasal polyps.
Multiple trials investigating novel medications to improve respiratory symptoms and patient quality of life.
Groundbreaking studies in heart failure prevention and cardiomyopathy, exploring new therapeutic options for various cardiovascular conditions.
Advanced research aimed at reducing cardiovascular events and improving patient outcomes.
Innovative research into treatments for systemic sclerosis and Sjögren's syndrome, focusing on novel therapeutic approaches for these challenging conditions.
Studies evaluating new biological treatments to address various autoimmune conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
